User profiles for Nicholas Easom

Nicholas Easom

Hull University Teaching Hospitals
Verified email at ucl.ac.uk
Cited by 10589

[HTML][HTML] Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

…, A De Soyza, ND Bakerly, N Easom… - The Lancet …, 2021 - thelancet.com
Background The impact of COVID-19 on physical and mental health and employment after
hospitalisation with acute disease is not well understood. The aim of this study was to …

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion

D Peppa, US Gill, G Reynolds, NJW Easom… - Journal of Experimental …, 2013 - rupress.org
Antiviral T cell responses in hepatotropic viral infections such as hepatitis B virus (HBV) are
profoundly diminished and prone to apoptotic deletion. In this study, we investigate whether …

IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection

…, F Robertson, N Hansi, NJW Easom… - Journal of Experimental …, 2017 - rupress.org
The liver provides a tolerogenic immune niche exploited by several highly prevalent pathogens
as well as by primary and metastatic tumors. We have sampled healthy and hepatitis B …

Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission

…, R Capstick, GD Barlow, N Easom… - Journal of …, 2020 - journalofinfection.com
In this Journal, Zhu et al. recently reported the results of their genomic analysis of multidrug-resistant
Klebsiella pneumoniae isolates from individual patients before and after colistin …

Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D

L Bacon, RA Eagle, M Meyer, N Easom… - The Journal of …, 2004 - journals.aai.org
We characterized two novel members of the RAET1/ULBP gene cluster, RAET1E and RAET1G.
The encoded proteins were similar to the ULBP in their class I-like α1 and α2 domains, …

[HTML][HTML] Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus …

…, V Lowthorpe, M Ivan, P Lillie, N Easom… - The Lancet …, 2023 - thelancet.com
Background COVID-19 has overwhelmed health services globally. Oral antiviral therapies
are licensed worldwide, but indications and efficacy rates vary. We aimed to evaluate the …

Physical, cognitive and mental health impacts of COVID-19 following hospitalisation–a multi-centre prospective cohort study

…, T Chalder, A De Soyza, N Diar Bakerly, N Easom… - MedRxiv, 2021 - medrxiv.org
Background The impact of COVID-19 on physical and mental health, and employment
following hospitalisation is poorly understood. Methods PHOSP-COVID is a multi-centre, UK, …

Lessons for managing high-consequence infections from first COVID-19 cases in the UK

P Moss, G Barlow, N Easom, P Lillie, A Samson - The Lancet, 2020 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of an ongoing
international outbreak of respiratory illness, known as coronavirus disease 2019 (COVID-19)…

[HTML][HTML] IL-15 overcomes hepatocellular carcinoma-induced NK cell dysfunction

NJW Easom, KA Stegmann, L Swadling… - Frontiers in …, 2018 - frontiersin.org
NK cells have potent antitumor capacity. They are enriched in the human liver, with a large
subset specialized for tissue-residence. The potential for liver-resident versus liver-infiltrating …

[HTML][HTML] Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

…, G Choudhury, ND Bakerly, N Easom… - The Lancet …, 2023 - thelancet.com
Introduction The multiorgan impact of moderate to severe coronavirus infections in the post-acute
phase is still poorly understood. We aimed to evaluate the excess burden of multiorgan …